Dr. Barbara Weber's insider stock trading activity reveals a pattern of strategic financial decisions. In June 2023, she executed a notable sale worth approximately $6.69 million, showcasing her confidence in Tango's trajectory. Her holdings peaked notably earlier in 2023, particularly...

Dr. Barbara Weber's insider stock trading activity reveals a pattern of strategic financial decisions. In June 2023, she executed a notable sale worth approximately $6.69 million, showcasing her confidence in Tango's trajectory. Her holdings peaked notably earlier in 2023, particularly around August, when her trades surpassed $9 million. This was likely influenced by significant developments in the company's clinical trials and advancements in drug discovery. The fluctuations in her stock activity highlight not only her active role in corporate governance but also an effort to balance personal investment risks with the company's growing value. As of December 2023, her market value in Tango stock reflects a considerable portion of her wealth, cementing her belief in the company's mission and future prospects.